Literature DB >> 14872272

[Effect of suramin on proliferation and migration of lens epithelial cells in vitro].

P W Rieck1, J Kriegsch, C Jaeckel, C Hartmann.   

Abstract

BACKGROUND: New approaches for the treatment of secondary cataract focus on a pharmacological therapy to prevent posterior capsule opacification. In this study we investigated the effect of the naphthylurea suramin in vitro in a cell culture model.
MATERIAL AND METHODS: Cell proliferation was measured using a proliferation assay and cell migration with a migration assay. Analyses of suramin toxicity were carried out using trypan blue staining.
RESULTS: A significant dose-dependent effect of suramin on the inhibition of LEC proliferation and migration was found even after short (1 or 2 h) incubation times ( p<0.01). Cell lysis reflecting a cytotoxic effect of suramin was not found even with high concentrations. However, preincubation of lens capsules with suramin did not prevent LECs from migrating compared to control cultures.
CONCLUSION: These results demonstrate the efficiency of suramin in vitro to inhibit migration of HLEC which can be explained by blocking growth factor-mediated effects on the cells. However, further investigations on the pharmacokinetic properties of suramin and possible side-effects on other intraocular tissues must follow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872272     DOI: 10.1007/s00347-003-0908-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  24 in total

1.  Preventing lens epithelial cell migration using intraocular lenses with sharp rectangular edges.

Authors:  O Nishi; K Nishi; K Wickström
Journal:  J Cataract Refract Surg       Date:  2000-10       Impact factor: 3.351

2.  The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro.

Authors:  A Schilling-Schön; U Pleyer; C Hartmann; P W Rieck
Journal:  Exp Eye Res       Date:  2000-12       Impact factor: 3.467

3.  Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin.

Authors:  Y Hu; Y Zou; H Dietrich; G Wick; Q Xu
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

4.  Prevention of secondary cataract by antimitotic drugs: experimental study.

Authors:  M M Ismail; J L Alió; J M Ruiz Moreno
Journal:  Ophthalmic Res       Date:  1996       Impact factor: 2.892

5.  Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.

Authors:  E De Clercq
Journal:  Cancer Lett       Date:  1979-11       Impact factor: 8.679

6.  Sharp-edged intraocular lens design as a cause of permanent glare.

Authors:  M F Ellis
Journal:  J Cataract Refract Surg       Date:  2001-07       Impact factor: 3.351

7.  Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes.

Authors:  C W Mahoney; A Azzi; K P Huang
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

8.  Inhibition of proliferating lens epithelium with antitransferrin receptor immunotoxin.

Authors:  K M Goins; J R Ortiz; S F Fulcher; J T Handa; G J Jaffe; G N Foulks; L M Cobo
Journal:  J Cataract Refract Surg       Date:  1994-09       Impact factor: 3.351

9.  Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.

Authors:  J Waltenberger; U Mayr; H Frank; V Hombach
Journal:  J Mol Cell Cardiol       Date:  1996-07       Impact factor: 5.000

Review 10.  Suramin's development: what did we learn?

Authors:  Maninderjeet Kaur; Eddie Reed; Oliver Sartor; William Dahut; William D Figg
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.651

View more
  2 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  Post-operative capsular opacification: a review.

Authors:  Shetal M Raj; Abhay R Vasavada; S R Kaid Johar; Vaishali A Vasavada; Viraj A Vasavada
Journal:  Int J Biomed Sci       Date:  2007-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.